SVA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinovac Biotech Ltd

Watchlist Manager

Watchlist

Price: 6.47 USD Market Closed

Market Cap: $644.7m

	Sinovac Biotech Ltd NASDAQ:SVA	CN
	Fomento de Construcciones y Contratas SA OTC:FMOCF	ES
	Prada SpA F:PRP	IT
S	Siemens AG XHAN:SIE	DE
M	Memphasys Ltd F:IG7	AU
H	HEM Pharma Inc KOSDAQ:376270	KR
L	Land Securities Group PLC F:LSU2	UK
	Barry Callebaut AG OTC:BRRLY	CH
I	Italgas SpA F:I10	IT
M	Medibank Private Ltd F:MPV	AU
A	AbClon Inc KOSDAQ:174900	KR

Profitability Summary

Sinovac Biotech Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

70%

Gross Margin is Increasing

-47% > 69%

Negative Operating Margin

-54%

Negative 3Y Average Operating Margin

-97%

Operating Margin is Increasing

-359% > -54%

Negative Net Margin

-24%

Negative 3Y Average Net Margin

-4%

Net Margin is Increasing

-86% > -24%

Negative Free Cash Flow Margin

-140%

Negative 3Y Average Free Cash Flow Margin

-71%

Declining Free Cash Flow Margin

-52% > -140%

Negative ROE

-2%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-25%

ROIC is Increasing

-48% > -5%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.